Skip to main content
Erschienen in: Journal of NeuroVirology 1/2011

01.02.2011

Development of co-selected single nucleotide polymorphisms in the viral promoter precedes the onset of human immunodeficiency virus type 1-associated neurocognitive impairment

verfasst von: Luna Li, Benjamas Aiamkitsumrit, Vanessa Pirrone, Michael R. Nonnemacher, Adam Wojno, Shendra Passic, Katherine Flaig, Evelyn Kilareski, Brandon Blakey, Jade Ku, Nirzari Parikh, Rushabh Shah, Julio Martin-Garcia, Brian Moldover, Laila Servance, David Downie, Sharon Lewis, Jeffrey M. Jacobson, Dennis Kolson, Brian Wigdahl

Erschienen in: Journal of NeuroVirology | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

The long terminal repeat (LTR) regulates gene expression of HIV-1 by interacting with multiple host and viral factors. Cross-sectional studies in the pre-HAART era demonstrated that single nucleotide polymorphisms (SNPs) in peripheral blood-derived LTRs (a C-to-T change at position 3 of C/EBP site I (3T) and at position 5 of Sp site III (5T)) increased in frequency as disease severity increased. Additionally, the 3T variant correlated with HIV-1-associated dementia. LTR sequences derived by longitudinal sampling of peripheral blood from a single patient in the DrexelMed HIV/AIDS Genetic Analysis Cohort resulted in the detection of the 3T and 5T co-selected SNPs before the onset of neurologic impairment, demonstrating that these SNPs may be useful in predicting HIV-associated neurological complications. The relative fitness of the LTRs containing the 3T and/or 5T co-selected SNPs as they evolve in their native patient-derived LTR backbone structure demonstrated a spectrum of basal and Tat-mediated transcriptional activities using the IIIB-derived Tat and colinear Tat derived from the same molecular clone containing the 3T/5T LTR SNP. In silico predictions utilizing colinear envelope sequence suggested that the patient’s virus evolved from an X4 to an R5 swarm prior to the development of neurological complications and more advanced HIV disease. These results suggest that the HIV-1 genomic swarm may evolve during the course of disease in response to selective pressures that lead to changes in prevalence of specific polymorphisms in the LTR, env, and/or tat that could predict the onset of neurological disease and result in alterations in viral function.
Literatur
Zurück zum Zitat Boven LA, Noorbakhsh F, Bouma G, van der Zee R, Vargas DL, Pardo C, McArthur JC, Nottet HS, Power C (2007) Brain-derived human immunodeficiency virus-1 Tat exerts differential effects on LTR transactivation and neuroimmune activation. J Neurovirol 13:173–184CrossRefPubMed Boven LA, Noorbakhsh F, Bouma G, van der Zee R, Vargas DL, Pardo C, McArthur JC, Nottet HS, Power C (2007) Brain-derived human immunodeficiency virus-1 Tat exerts differential effects on LTR transactivation and neuroimmune activation. J Neurovirol 13:173–184CrossRefPubMed
Zurück zum Zitat Brockman W, Alvarez P, Young S, Garber M, Giannoukos G, Lee WL, Russ C, Lander ES, Nusbaum C, Jaffe DB (2008) Quality scores and SNP detection in sequencing-by-synthesis systems. Genome Res 18:763–770CrossRefPubMed Brockman W, Alvarez P, Young S, Garber M, Giannoukos G, Lee WL, Russ C, Lander ES, Nusbaum C, Jaffe DB (2008) Quality scores and SNP detection in sequencing-by-synthesis systems. Genome Res 18:763–770CrossRefPubMed
Zurück zum Zitat Burdo TH, Gartner S, Mauger D, Wigdahl B (2004) Region-specific distribution of human immunodeficiency virus type 1 long terminal repeats containing specific configurations of CCAAT/enhancer-binding protein site II in brains derived from demented and nondemented patients. J Neurovirol 10(Suppl 1):7–14PubMed Burdo TH, Gartner S, Mauger D, Wigdahl B (2004) Region-specific distribution of human immunodeficiency virus type 1 long terminal repeats containing specific configurations of CCAAT/enhancer-binding protein site II in brains derived from demented and nondemented patients. J Neurovirol 10(Suppl 1):7–14PubMed
Zurück zum Zitat Chun TW, Carruth L, Finzi D, Shen X, DiGiuseppe JA, Taylor H, Hermankova M, Chadwick K, Margolick J, Quinn TC, Kuo YH, Brookmeyer R, Zeiger MA, Barditch-Crovo P, Siliciano RF (1997) Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 387:183–188CrossRefPubMed Chun TW, Carruth L, Finzi D, Shen X, DiGiuseppe JA, Taylor H, Hermankova M, Chadwick K, Margolick J, Quinn TC, Kuo YH, Brookmeyer R, Zeiger MA, Barditch-Crovo P, Siliciano RF (1997) Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 387:183–188CrossRefPubMed
Zurück zum Zitat de Jong JJ, Goudsmit J, Keulen W, Klaver B, Krone W, Tersmette M, de Ronde A (1992) Human immunodeficiency virus type 1 clones chimeric for the envelope V3 domain differ in syncytium formation and replication capacity. J Virol 66:757–765PubMed de Jong JJ, Goudsmit J, Keulen W, Klaver B, Krone W, Tersmette M, de Ronde A (1992) Human immunodeficiency virus type 1 clones chimeric for the envelope V3 domain differ in syncytium formation and replication capacity. J Virol 66:757–765PubMed
Zurück zum Zitat Fields BN, Knipe DM, Howley PM, Griffin DE (2001) Fields’ virology, 4th edn. Lippincott Williams & Wilkins, Philadelphia Fields BN, Knipe DM, Howley PM, Griffin DE (2001) Fields’ virology, 4th edn. Lippincott Williams & Wilkins, Philadelphia
Zurück zum Zitat Fields BN, Knipe DM, Howley PM (2007) Fields’ virology, 5th edn. Wolters Kluwer Health, Philadelphia Fields BN, Knipe DM, Howley PM (2007) Fields’ virology, 5th edn. Wolters Kluwer Health, Philadelphia
Zurück zum Zitat Fouchier RA, Groenink M, Kootstra NA, Tersmette M, Huisman HG, Miedema F, Schuitemaker H (1992) Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. J Virol 66:3183–3187PubMed Fouchier RA, Groenink M, Kootstra NA, Tersmette M, Huisman HG, Miedema F, Schuitemaker H (1992) Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. J Virol 66:3183–3187PubMed
Zurück zum Zitat Gao F, Robertson DL, Morrison SG, Hui H, Craig S, Decker J, Fultz PN, Girard M, Shaw GM, Hahn BH, Sharp PM (1996) The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin. J Virol 70: 7013–7029 Gao F, Robertson DL, Morrison SG, Hui H, Craig S, Decker J, Fultz PN, Girard M, Shaw GM, Hahn BH, Sharp PM (1996) The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin. J Virol 70: 7013–7029
Zurück zum Zitat Garcia-Crespo K, Cadilla C, Skolasky R, Melendez LM (2010) Restricted HIV-1 replication in placental macrophages is caused by inefficient viral transcription. J Leukoc Biol 87:633–636CrossRefPubMed Garcia-Crespo K, Cadilla C, Skolasky R, Melendez LM (2010) Restricted HIV-1 replication in placental macrophages is caused by inefficient viral transcription. J Leukoc Biol 87:633–636CrossRefPubMed
Zurück zum Zitat Gasteiger E, Hoogland C, Gattiker A, Duvaud S, Wilkins MR, Appel RD, Bairoch A (2005) Protein identification and analysis tools on the ExPASy server. Humana, Totowa Gasteiger E, Hoogland C, Gattiker A, Duvaud S, Wilkins MR, Appel RD, Bairoch A (2005) Protein identification and analysis tools on the ExPASy server. Humana, Totowa
Zurück zum Zitat Henderson AJ, Calame KL (1997) CCAAT/enhancer binding protein (C/EBP) sites are required for HIV-1 replication in primary macrophages but not CD4(+) T cells. Proc Natl Acad Sci USA 94:8714–8719CrossRefPubMed Henderson AJ, Calame KL (1997) CCAAT/enhancer binding protein (C/EBP) sites are required for HIV-1 replication in primary macrophages but not CD4(+) T cells. Proc Natl Acad Sci USA 94:8714–8719CrossRefPubMed
Zurück zum Zitat Henderson AJ, Zou X, Calame KL (1995) C/EBP proteins activate transcription from the human immunodeficiency virus type 1 long terminal repeat in macrophages/monocytes. J Virol 69:5337–5344PubMed Henderson AJ, Zou X, Calame KL (1995) C/EBP proteins activate transcription from the human immunodeficiency virus type 1 long terminal repeat in macrophages/monocytes. J Virol 69:5337–5344PubMed
Zurück zum Zitat Henderson AJ, Connor RI, Calame KL (1996) C/EBP activators are required for HIV-1 replication and proviral induction in monocytic cell lines. Immunity 5:91–101CrossRefPubMed Henderson AJ, Connor RI, Calame KL (1996) C/EBP activators are required for HIV-1 replication and proviral induction in monocytic cell lines. Immunity 5:91–101CrossRefPubMed
Zurück zum Zitat Ho SH, Tasca S, Shek L, Li A, Gettie A, Blanchard J, Boden D, Cheng-Mayer C (2007) Coreceptor switch in R5-tropic simian/human immunodeficiency virus-infected macaques. J Virol 81:8621–8633CrossRefPubMed Ho SH, Tasca S, Shek L, Li A, Gettie A, Blanchard J, Boden D, Cheng-Mayer C (2007) Coreceptor switch in R5-tropic simian/human immunodeficiency virus-infected macaques. J Virol 81:8621–8633CrossRefPubMed
Zurück zum Zitat Hogan TH, Stauff DL, Krebs FC, Gartner S, Quiterio SJ, Wigdahl B (2003) Structural and functional evolution of human immunodeficiency virus type 1 long terminal repeat CCAAT/enhancer binding protein sites and their use as molecular markers for central nervous system disease progression. J Neurovirol 9:55–68PubMed Hogan TH, Stauff DL, Krebs FC, Gartner S, Quiterio SJ, Wigdahl B (2003) Structural and functional evolution of human immunodeficiency virus type 1 long terminal repeat CCAAT/enhancer binding protein sites and their use as molecular markers for central nervous system disease progression. J Neurovirol 9:55–68PubMed
Zurück zum Zitat Hughes ES, Bell JE, Simmonds P (1997) Investigation of the dynamics of the spread of human immunodeficiency virus to brain and other tissues by evolutionary analysis of sequences from the p17 gag and env genes. J Virol 71:1272–1280PubMed Hughes ES, Bell JE, Simmonds P (1997) Investigation of the dynamics of the spread of human immunodeficiency virus to brain and other tissues by evolutionary analysis of sequences from the p17 gag and env genes. J Virol 71:1272–1280PubMed
Zurück zum Zitat Jensen MA, van’t Wout AB (2003) Predicting HIV-1 coreceptor usage with sequence analysis. AIDS Rev 5:104–112PubMed Jensen MA, van’t Wout AB (2003) Predicting HIV-1 coreceptor usage with sequence analysis. AIDS Rev 5:104–112PubMed
Zurück zum Zitat Jensen MA, Li FS, van’t Wout AB, Nickle DC, Shriner D, He HX, McLaughlin S, Shankarappa R, Margolick JB, Mullins JI (2003) Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences. J Virol 77:13376–13388CrossRefPubMed Jensen MA, Li FS, van’t Wout AB, Nickle DC, Shriner D, He HX, McLaughlin S, Shankarappa R, Margolick JB, Mullins JI (2003) Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences. J Virol 77:13376–13388CrossRefPubMed
Zurück zum Zitat Jones KA, Kadonaga JT, Luciw PA, Tjian R (1986) Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1. Science 232:755–759CrossRefPubMed Jones KA, Kadonaga JT, Luciw PA, Tjian R (1986) Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1. Science 232:755–759CrossRefPubMed
Zurück zum Zitat Kim JY, Gonzalez-Scarano F, Zeichner SL, Alwine JC (1993) Replication of type 1 human immunodeficiency viruses containing linker substitution mutations in the −201 to −130 region of the long terminal repeat. J Virol 67:1658–1662PubMed Kim JY, Gonzalez-Scarano F, Zeichner SL, Alwine JC (1993) Replication of type 1 human immunodeficiency viruses containing linker substitution mutations in the −201 to −130 region of the long terminal repeat. J Virol 67:1658–1662PubMed
Zurück zum Zitat Kitchen SG, Jones NR, LaForge S, Whitmire JK, Vu BA, Galic Z, Brooks DG, Brown SJ, Kitchen CM, Zack JA (2004) CD4 on CD8(+) T cells directly enhances effector function and is a target for HIV infection. Proc Natl Acad Sci USA 101:8727–8732CrossRefPubMed Kitchen SG, Jones NR, LaForge S, Whitmire JK, Vu BA, Galic Z, Brooks DG, Brown SJ, Kitchen CM, Zack JA (2004) CD4 on CD8(+) T cells directly enhances effector function and is a target for HIV infection. Proc Natl Acad Sci USA 101:8727–8732CrossRefPubMed
Zurück zum Zitat Marozzi A, Meneveri R, Giacca M, Gutierrez MI, Siccardi AG, Ginelli E (1998) In vitro selection of HIV-1 TAR variants by the Tat protein. J Biotechnol 61:117–128CrossRefPubMed Marozzi A, Meneveri R, Giacca M, Gutierrez MI, Siccardi AG, Ginelli E (1998) In vitro selection of HIV-1 TAR variants by the Tat protein. J Biotechnol 61:117–128CrossRefPubMed
Zurück zum Zitat McAllister JJ, Phillips D, Millhouse S, Conner J, Hogan T, Ross HL, Wigdahl B (2000) Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication. Virology 274:262–277CrossRefPubMed McAllister JJ, Phillips D, Millhouse S, Conner J, Hogan T, Ross HL, Wigdahl B (2000) Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication. Virology 274:262–277CrossRefPubMed
Zurück zum Zitat Moses AV, Ibanez C, Gaynor R, Ghazal P, Nelson JA (1994) Differential role of long terminal repeat control elements for the regulation of basal and Tat-mediated transcription of the human immunodeficiency virus in stimulated and unstimulated primary human macrophages. J Virol 68:298–307PubMed Moses AV, Ibanez C, Gaynor R, Ghazal P, Nelson JA (1994) Differential role of long terminal repeat control elements for the regulation of basal and Tat-mediated transcription of the human immunodeficiency virus in stimulated and unstimulated primary human macrophages. J Virol 68:298–307PubMed
Zurück zum Zitat Nonnemacher MR, Irish BP, Liu Y, Mauger D, Wigdahl B (2004) Specific sequence configurations of HIV-1 LTR G/C box array result in altered recruitment of Sp isoforms and correlate with disease progression. J Neuroimmunol 157:39–47CrossRefPubMed Nonnemacher MR, Irish BP, Liu Y, Mauger D, Wigdahl B (2004) Specific sequence configurations of HIV-1 LTR G/C box array result in altered recruitment of Sp isoforms and correlate with disease progression. J Neuroimmunol 157:39–47CrossRefPubMed
Zurück zum Zitat Pantaleo G, Graziosi C, Fauci AS (1993) New concepts in the immunopathogenesis of human immunodeficiency virus infection. N Engl J Med 328:327–335CrossRefPubMed Pantaleo G, Graziosi C, Fauci AS (1993) New concepts in the immunopathogenesis of human immunodeficiency virus infection. N Engl J Med 328:327–335CrossRefPubMed
Zurück zum Zitat Pereira LA, Bentley K, Peeters A, Churchill MJ, Deacon NJ (2000) A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter. Nucleic Acids Res 28:663–668CrossRefPubMed Pereira LA, Bentley K, Peeters A, Churchill MJ, Deacon NJ (2000) A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter. Nucleic Acids Res 28:663–668CrossRefPubMed
Zurück zum Zitat Peters PJ, Duenas-Decamp MJ, Sullivan WM, Clapham PR (2007) Variation of macrophage tropism among HIV-1 R5 envelopes in brain and other tissues. J Neuroimmune Pharmacol 2:32–41CrossRefPubMed Peters PJ, Duenas-Decamp MJ, Sullivan WM, Clapham PR (2007) Variation of macrophage tropism among HIV-1 R5 envelopes in brain and other tissues. J Neuroimmune Pharmacol 2:32–41CrossRefPubMed
Zurück zum Zitat Pirrone V, Passic S, Wigdahl B, Rando RF, Labib M, Krebs FC (2010) A styrene-alt-maleic acid copolymer is an effective inhibtor of R5 and X4 human immunodeficiency virus type 1 infection. J Biomed Biotechnol 2010:548749. doi:10.1155/2010/548749 Pirrone V, Passic S, Wigdahl B, Rando RF, Labib M, Krebs FC (2010) A styrene-alt-maleic acid copolymer is an effective inhibtor of R5 and X4 human immunodeficiency virus type 1 infection. J Biomed Biotechnol 2010:548749. doi:10.​1155/​2010/​548749
Zurück zum Zitat Price RW, Brew BJ (1988) The AIDS dementia complex. J Infect Dis 158:1079–1083PubMed Price RW, Brew BJ (1988) The AIDS dementia complex. J Infect Dis 158:1079–1083PubMed
Zurück zum Zitat Ross EK, Buckler-White AJ, Rabson AB, Englund G, Martin MA (1991) Contribution of NF-kappa B and Sp1 binding motifs to the replicative capacity of human immunodeficiency virus type 1: distinct patterns of viral growth are determined by T-cell types. J Virol 65:4350–4358PubMed Ross EK, Buckler-White AJ, Rabson AB, Englund G, Martin MA (1991) Contribution of NF-kappa B and Sp1 binding motifs to the replicative capacity of human immunodeficiency virus type 1: distinct patterns of viral growth are determined by T-cell types. J Virol 65:4350–4358PubMed
Zurück zum Zitat Ross HL, Gartner S, McArthur JC, Corboy JR, McAllister JJ, Millhouse S, Wigdahl B (2001) HIV-1 LTR C/EBP binding site sequence configurations preferentially encountered in brain lead to enhanced C/EBP factor binding and increased LTR-specific activity. J Neurovirol 7:235–249CrossRefPubMed Ross HL, Gartner S, McArthur JC, Corboy JR, McAllister JJ, Millhouse S, Wigdahl B (2001) HIV-1 LTR C/EBP binding site sequence configurations preferentially encountered in brain lead to enhanced C/EBP factor binding and increased LTR-specific activity. J Neurovirol 7:235–249CrossRefPubMed
Zurück zum Zitat Sacktor NC, Wong M, Nakasujja N, Skolasky RL, Selnes OA, Musisi S, Robertson K, McArthur JC, Ronald A, Katabira E (2005) The international HIV dementia scale: a new rapid screening test for HIV dementia. AIDS 19:1367–1374PubMed Sacktor NC, Wong M, Nakasujja N, Skolasky RL, Selnes OA, Musisi S, Robertson K, McArthur JC, Ronald A, Katabira E (2005) The international HIV dementia scale: a new rapid screening test for HIV dementia. AIDS 19:1367–1374PubMed
Zurück zum Zitat Shioda T, Levy JA, Cheng-Mayer C (1992) Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell-line and macrophage tropism of human immunodeficiency virus type 1. Proc Natl Acad Sci USA 89:9434–9438CrossRefPubMed Shioda T, Levy JA, Cheng-Mayer C (1992) Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell-line and macrophage tropism of human immunodeficiency virus type 1. Proc Natl Acad Sci USA 89:9434–9438CrossRefPubMed
Zurück zum Zitat van Marle G, Power C (2005) Human immunodeficiency virus type 1 genetic diversity in the nervous system: evolutionary epiphenomenon or disease determinant? J Neurovirol 11:107–128CrossRefPubMed van Marle G, Power C (2005) Human immunodeficiency virus type 1 genetic diversity in the nervous system: evolutionary epiphenomenon or disease determinant? J Neurovirol 11:107–128CrossRefPubMed
Zurück zum Zitat Zeichner SL, Kim JY, Alwine JC (1991) Linker-scanning mutational analysis of the transcriptional activity of the human immunodeficiency virus type 1 long terminal repeat. J Virol 65:2436–2444PubMed Zeichner SL, Kim JY, Alwine JC (1991) Linker-scanning mutational analysis of the transcriptional activity of the human immunodeficiency virus type 1 long terminal repeat. J Virol 65:2436–2444PubMed
Zurück zum Zitat Zhu T, Mo H, Wang N, Nam DS, Cao Y, Koup RA, Ho DD (1993) Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science 261:1179–1181CrossRefPubMed Zhu T, Mo H, Wang N, Nam DS, Cao Y, Koup RA, Ho DD (1993) Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science 261:1179–1181CrossRefPubMed
Metadaten
Titel
Development of co-selected single nucleotide polymorphisms in the viral promoter precedes the onset of human immunodeficiency virus type 1-associated neurocognitive impairment
verfasst von
Luna Li
Benjamas Aiamkitsumrit
Vanessa Pirrone
Michael R. Nonnemacher
Adam Wojno
Shendra Passic
Katherine Flaig
Evelyn Kilareski
Brandon Blakey
Jade Ku
Nirzari Parikh
Rushabh Shah
Julio Martin-Garcia
Brian Moldover
Laila Servance
David Downie
Sharon Lewis
Jeffrey M. Jacobson
Dennis Kolson
Brian Wigdahl
Publikationsdatum
01.02.2011
Verlag
Springer US
Erschienen in
Journal of NeuroVirology / Ausgabe 1/2011
Print ISSN: 1355-0284
Elektronische ISSN: 1538-2443
DOI
https://doi.org/10.1007/s13365-010-0014-1

Weitere Artikel der Ausgabe 1/2011

Journal of NeuroVirology 1/2011 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.